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SUMMARY 
Adult female Swiss mice showed a greater resistance to intraperitoneal (i.p.) 
infection with encephalomyocarditis virus (EMCV) than male mice. This difference 
was not observed in weanling mice, in castrated adult mice or in adult mice injected 
intracerebrally. Administration of antibody to mouse interferon ~/# enhanced the 
virulence of EMCV for both sexes and no difference was then observed in 
susceptibility between male and female mice. Six h after EMCV infection, serum 
interferon titres were higher in adult female mice than in male mice. There was a close 
correlation between the early serum interferon titre (at 6 h) and survival of EMCV- 
infected mice. No differences in serum interferon titres were observed between male or 
female weanling mice or castrated adult mice. Potent preparations of exogenous 
interferon provided the same degree of protection against EMCV infection in male and 
female mice. We conclude that the more marked early interferon response of female 
mice to i.p. EMCV infection is one of the important factors underlying the differential 
susceptibility oEMCV. It is possible that the interferon system is also involved in the 
reported greater prevalence of picornavirus infections of men compared with women. 
INTRODUCTION 
Males are more susceptible than females to infection with picornaviruses. Despite the same 
incidence of infection in humans of both sexes with enteroviruses, the clinical manifestations of 
such diseases are gularly more severe in men than women as exemplified by poliomyelitis 
(Weinstein, 1957), coxsackievirus myocarditis (Woodruff, 1980), non-polio-enterovirus diseases 
(Nelson et al., 1979; Morens et al., 1979) and hepatitis A (McCollum, 1976) the causative agent 
of which is related to enteroviruses (Gust et al., 1983). Several studies have demonstrated that 
male mice are more susceptible than female mice to experimental infections with coxsackie BI
(Berkovich & Ressel, 1965, 1967) and B3 viruses (Wong et al., 1977; Huber et al., 1981a, b, 
1982). Sex hormones and sex differences in the cytotoxic T-cell responses were implicated, but 
no satisfactory mechanism ofaction has been proposed to explain the enhanced susceptibility of
males (or the resistance of females). 
Encephalomyocarditis virus (EMCV), which, like enteroviruses, belongs to the Picornaviri- 
dae family, was also shown to be more virulent in male mice than in female mice (Weinstein & 
Chang, 1961 ;Friedman et al., 1972; Boucher et al., 1975). Friedman et al. (1972) emphasized the 
role of sex hormones in this phenomenon, since castration of male mice resulted in a pattern of 
resistance similar to that of female mice, whereas castration of female mice did not affect heir 
susceptibility to EMCV. Furthermore, in this model, testosterone and oestradiol, but not 
progesterone, markedly increased the sensitivity of castrated mice of both sexes to EMCV 
(Friedman et at., 1972). 
The results of some recent studies have emphasized the importance ofthe 'early' production of 
interferon in resistance of adult mice to herpes simplex virus infection (Engler et al., 1982; 
Zawatzky et al., 1982a, b) and the influence of sex in determining the extent of this early 
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interferon production in mice infected with herpes simplex virus (Zawatzky et al., 1982c; 
Pedersen et al., 1983) or Newcastle disease virus (DeMaeyer-Guignard et al., 1982). In the 
present study, we report the influence of various factors on the sex-related sensitivity of Swiss 
mice to EMCV. Our results suggest hat the early interferon response is an important factor 
underlying the differential susceptibility to EMCV of male and female Swiss mice. 
METHODS 
Mice. Male and female Swiss, C57BL/6 and DBA/2 mice were obtained from the pathogen-free colonies at the 
Institut du Cancer, Villejuif, France. 
EMC Vand assay o[ antibodies to it. The origin, methods of preparation and assay of the EMCV used in this study 
have been previously described (Gresser et aL, 1968). The titre of the EMCV stock used in all the experiments in 
t'ivo was 10 '~'3 TCIDso per 0-2 ml in monolayer cultures of L cells. Mice were injected intraperitoneally (i.p.), or 
subcutaneously (s.c.) with 0.2 ml, or intracerebrally (i.c.) with 0.03 ml of the given virus stock dilution(s). Although 
the majority of deaths occurred in the 10 days following EMCV infection, mice were kept 3 to 4 weeks longer. 
EMCV infectivity in mouse serum was assayed by serial tenfold ilutions in L cell cultures in microplates. Serum 
antibodies toEMCV were titrated by serum-neutralization ests: serial twofold ilutions were assayed against 100 
TCIDs, of EMCV for inhibition of cytopathic effect in L cells. 
Procedure lor castration and hormonal treatments. Four-week-old Swiss mice were anaesthetized by i.p. injection 
of 0.15 to 0.25 ml ImalgeneR/500 (containing 50 mg/ml ketamine; I FFA M6rieux, les Oncins, France). Removal of 
the ovaries was performed through a single dorsal incision. The testes were removed through aslit in the scrotal 
sac. Sham-operated mice were anaesthetized and incised like castrated mice but without resection of gonads. 
Long-acting preparations of sex hormones were diluted with peanut oil and injected intramuscularly once a week 
in castrated Swiss mice: 0.5 mg/0.1 ml for testosterone h xahydrobenzoate nd0.1 mg/0.1 ml for oestradiol 
hexahydrobenzoate. 
Mouse interJeron and sheep anti-mouse interJeron globulin. The techniques used in the production, partial 
purification and assay of mouse C-243 cell interferon (Tovey et al., 1974) or sheep anti-mouse interferon globulin 
have been previously described (Gresser et al., 1976). Mouse interferon had a titre of 1.6 x 106 laboratory units 
against vesicular stomatitis viru~(VSV) on L cells. The neutralizing titre of the anti-interferon serum was 3.2 x 
10 ° against 4to 8 laboratory units of interferon. In the experiments, 0-2 ml of these preparations were injected i.p. 
at 1:1, 1:10 and 1:100 dilutions for mouse interferon and 1:20 for anti-interferon globulin. 
Induction and assay oJendogenous interJeron in mice. Interferon was induced by i.p. inoculation of 107`6 TC1D50 of 
EMCV. At given times, mice were exsanguinated, sera were diluted 1:5 in cell culture medium and dialysed for 6 
to 8 days against apH 2 buffer solution at4'~C. Interferon was assayed by inhibition of cytopathic effect of VSV in 
monolayer cultures of L cells in plastic microplates (0.2 ml/well) as previously described (Gresser et al., 1969). Or, e 
of our units is the equivalent of 4 international mouse reference units. 
Preparation of EMCV vaccine and vaccination procedure. The method of preparation ofan anti-EMCV vaccine, 
adapted from Frantzen (1948). consisted of treating the supernatant fluid from a culture of L cells infected with 
EMCV with 1~ formalin for I8 h at 4 °C. The vaccine was then diatysed for 3 to 4 days against phosphate- 
buffered saline, sterilized by filtration through a 0.22 ~tm filter, tested for infectivity on L cells and stored at 
- 70 "C. After three i.p. injections of 0.2 ml of undiluted vaccine at intervals of 3 days, more than 90~. o of mice 
were protected against l0 s LDso of virulent EMCV. 
Statisticalanalysis. LDs0 and TCIDso were calculated by the method of Reed & Muench (1938) and the standard 
errors (S.E.50) were estimated by the method of Pizzi (1950). Other statistical estimations u ed standard parametric 
tests: Chi square for comparison ofqualitative variables, Student's t-test for comparison ofmeans and the Pearson 
r coefficient for correlation analysis. 
RESULTS 
Factors involved in the susceptibility o f  male and female  mice to EMCV 
Table 1 summarizes the results of 12 exper iments  in which we invest igated the role of mouse 
age, route of  infection and mouse strain on the susceptibi l ity of male and female mice to EMCV 
infection. Swiss adult male mice were consistently more susceptible to i.p. inoculat ion of EMCV 
than female mice. It was of  interest o note, however,  that this difference was not observed in 
3-week-old mice. When Swiss mice were injected s.c., this difference in susceptibi l ity between 
male and female mice was not statistically significant. Likewise, no difference was observed 
when the virus was injected i.e. (Table 1). 
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Table  1. Response of male and Jemale mice to injection with EMCV:  roles of mouse strain, age 
and route of infection 
No. of mice per LDs0* + S.E.50 
Age Route of dilution per c "~ 
Strain (weeks) infection sex Males Females P value 
Swiss 3 i.p. 10 6.19 _+ 0.34t 5.71 _ 0.33 ys:~ 
Swiss 4 i.p. 15 6-32 _+ 0.18 5.67 _+ 0.24 <0.03 
Swiss 5 i.p. 8 5.88 _+ 0.32 4.71 _+ 0.29 <0-01 
Swiss 8 i.p. 8 5.80 _+ 0.28 4.88 + 0.25 <0.02 
Swiss 20 i.p. 10 6.16 _+ 0.38 4.82 _+ 0.32 <0.01 
Swiss 5-6 s.c. 8 6-71 _+ 0.29 5.88 + 0.35 NS 
Swiss 7 8 s.c. 15 5-89 + 0-24 5.33 _+0.29 NS 
Swiss 5 6 i.c. 8 8-80 + 0-30 8.70 + 0.27 NS 
DBA/2 4 5 i.p. 8 6.67 + 0.28 6.21 + 0.47 NS 
DBA/2 7 8 i.p. 15 6-00 + 0.27 5.66 + 0.26 NS 
C57BL/6 4 i.p. 8 6.41 + 0.27 6.33 + 0.33 NS 
BALB/c 4 i.p. 8 6-38 + 0-25 6.00 + 0.37 NS 
* Each LDso was calculated on the mortality ratios of at least four log~0 EMCV dilutions. 
] LDso and S.E.50 are expressed as log~,. 
NS, Not significant. 
Table  2. Influence of castration and hormone treatment on the susceptibility of male and female 
Swiss mice to i.p. injection of EMCV 
Age at EMCV Mortality 
infection 
(weeks)* 
56  
~k 
r 
Treatmenfff Males Females P value:~ 
None 13/16 (81 °/0)11 7/16 (44°.0) <0-03 
Castration 7/12 (58°~) 8/11 (73°.0) NS¶ 
None 23/26 (88 °~) 13/24 (54 °/) <0.01 
Sham operation 19/26 (73%) 16/26 (62%) NS 
Castration 14/25 (56°o) 21/25 (84 0'~) <0.04 
Castration + testosterone 19/24 (79 of) 22/24 (92 ~'o) Ns 
Castration + oestradiol§ 22/24 (9,.,o) 20/25 (80°.0) NS 
None 10/10 (100}o) 5/12 (42 °/) <0.01 
Castration 6/11 (55°/0) 6/8 (75%) NS 
* Swiss mice were rejected at various ages with 0-2 ml i.p. of 104.3 TC1Dso of EMCV. 
t Surgery was performed at 4 weeks of age. 
:~ P values were calculated with the Chi square test. 
§ Long-acting preparations of sex hormones were injected once a week for 3 weeks as described in the text. The 
difference between castrated, andcastrated and testosterone-treated mice was significant for male mice (P < 0-1) 
but not for female mice. The difference between castrated, and castrated and oestradiot-treated mice was highly 
significant for male mice (P < 0.01) and not significant for female mice. 
II Number of dead mice/total number of mice (percentage of deaths). 
¶ ys, Not significant. 
There  was no signif icant difference in morta l i ty  between male and  female DBA/2 ,  C57BL/6  
and BALB/c  mice after i.p. in ject ion with EMCV (Table l). However ,  in all these strains, and  
especial ly in DBA/2  mice, the evolut ion of disease was more rapid in male than  in female mice. 
Effect of castration and hormone treatment on the susceptibiliO' of  Swiss mice to EMCV infection 
Four-week-old Swiss mice were castrated and 2, 3 or 4 weeks later in jected with 0.2 ml i.p. of 
10 +3 TCIDs0 of EMCV.  As shown in Tab le  2, 5- to 8-week-old mice were more suscept ib le to 
EMCV than  female mice in accord wi th  the results presented above.  In each exper iment  
castrat ion rendered male mice more res istant and  female mice more suscept ible to EMCV than  
unoperated mice, and  in one exper iment  castrated female mice were even more suscept ible than  
castrated male mice (Table 2). In the same exper iment ,  sham-operated  male  mice exhib i ted a 
susceptibi l i ty in termediate  between castrated and non-operated male mice (Table 2). Af ter  
704 
Table 3. 
B. POZZETTO AND I.  GRESSER 
Effect of anti-interferon globulin on the susceptibility of maleand female Swiss mice to 
EMC V 
LDso* +_ s.l~.so 
A. 
t ~ -~ 
Treatment Males Females P value 
None 6.29 _+ 0.40:~ 5.12 + 0.41 <0.05 
Anti-interferon 8-10 + 0.38 8.50 _+ 0.25 NS§ 
globulint 
* LDso were calculated on the mortality ratios in mice injected with five log10 EMCV dilutions, There were 
eight mice per group per sex. 
t Five-week-old Swiss mice were injected i.p. with 0.2 ml of a 1 : 10 dilution of anti-interferon globulin 3 days 
before injection f virus. 
:~ LDso and S.E.5~ are expressed as log, 0. 
§ NS, Not significant. 
sacrifice of surviving mice, we noted that the testes has ascended in sham-operated mice. 
Although the testes appeared grossly normal it is possible that the production or secretion of 
hormones was affected by the sham operation. 
It was considered of interest o determine the effect of injection of testosterone or oestradiol 
on the susceptibility of castrated male and female mice to EMCV. Accordingly, 7-week-old 
castrated mice were injected intramuscularly 3 times with long-acting preparations of either 
hormone 10 and 3 days prior and 4 days after i.p, inoculation of EMCV. Both treatments 
increased the susceptibility of castrated male mice to EMCV and exerted no protective ffect in 
castrated females whose susceptibility to EMCV was increased compared with normal female 
mice (Table 2). 
Effect of injection of anti-interferon globulin on the susceptibility of male and female mice to 
EMC V 
As we had previously demonstrated the important role of interferon on the evolution of 
EMCV infection in mice by the use of antibody to mouse interferon c~/fl (Gresser et al., 1976), it 
was of interest o compare its effect in virus-infected male and female mice. As previously 
observed (Gresser et al., 1976), injection of anti-interferon globulin considerably enhanced the 
susceptibility of both male and female mice to EMCV (Table 3), resulting in a LD5o close to that 
observed in mice injected i.c. (see Table 1). However, injection of anti-interferon globulin 
abolished the difference in susceptibility between male and female mice (Table 3). 
Presence of endogenous interferon in male and female mice after infection with EMCV 
The finding that injection of anti-interferon globulin abrogated the difference in susceptibility 
between male and female mice suggested that interferon might be one of the factors underlying 
the different response of male and female Swiss mice to i.p. infection with EMCV. As shown in 
Fig. 1~ the overall serum interferon titres in male and female mice infected with EMCV were 
similar. However, 6 h after virus inoculation, the mean serum interferon titres in female mice 
were significantly greater (P < 0.05 by Student's t-test). Prior to 6 h only trace amounts of 
interferon were present in the sera and after 7 h a significant difference was no longer observed 
between male and female mice. Other experiments were performed to verify the difference in 
early interferon levels. The sera of a total of 22 mice of each sex were assayed at 6 h after EMCV 
infection. The mean serum interferon titres were significantly greater in female mice (4.67 _+ 
1.54 log_, IFN units versus 3.70 _+ 1-25 in male mice; Student's t-test = 2.33, P < 0.05). 
In view of these results it was of interest that serum EMCV titres were higher in male than in 
female mice at 12 and 18 h after virus infection (Fig. 2). 
Influence of age and sex on the serum interferon titre 
As a significant difference in the serum interferon titre was observed between male and 
female mice 6 h after EMCV infection, we examined in more detail the effect of age, sex and 
castration on the serum interferon titre at this time. At 3 weeks of age, no difference in 
Early interferon and sex in EMCV infection 
m .¢ . !  
I I I I I 
1 I 
// 
m / 
2 t I I ., I 
0 6 9 12 18 24 48 
Time after infection (h) 
Fig. 1. Serum interferon titres in male and female Swiss mice after infection with EMCV. Four-week* 
old Swiss mice were injected i.p. with 107.6 TCIDs0 of EMCV. Each point represents the mean 
interferon titre for six male ( , )  and six female (O)  mice. 
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Fig. 2. Titres of EMCV in sera of male and female Swiss mice. Experimental conditions are as in the 
legend to Fig. 1. Each column indicates the mean and standard deviation of EMCV titres from 6 to 11 
male ([~) or female (k~) mice. Student's t-test was used for statistical analysis. NS, Not significant. 
susceptibility to EMCV was observed between male and female mice, and there was no 
difference in the serum interferon titre between 3-week-old male and female mice 6 h after 
EMCV infection (Table 4). In contrast, older male mice (4 to 12 weeks) were consistently more 
susceptible to EMCV than female mice and the serum interferon titre at 6 h was consistently 
lower in male mice than in female mice (Table 4). 
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Table 4. Influence of age and sex on the 'early' serum interJeron titre in Swiss mice 
Age at EMCV 
infection 
(weeks)* 
3 
Sex 
M 
F 
M 
F 
7 M 
F 
8 M 
M 
F 
F 
12 M 
M 
F 
F 
45 
Number of Mean IFN titre 
Treatmentt mice (log2 + s.D.)~ P value§ 
None 12 4.57 + 1.57"~. 
None 12 4.83 ___ 0.97f NsJl 
None 22 3.70 + 1.25"~ 
None 22 4.67 ___ 1.54J <0.05 
None 12 3-92 + 0.83"~ 
None 12 4-58 + 0.75) <0.05 
None 12 3.65 + 0-96"] 
Castration 12 4.57 + 1 .25~]  <0-001 
None 12 5.20 + 0 .83 J~ NS 
Castration 12 4.32 ~_ 0.92 .) 
None 11 3.65 + 0.84"] 
Castration 11 4.21 + 1.31 ~-'] <0.01 
None 9 4.83 + 0.41J ~- ys 
Castration 11 4-46 &- 1.06 .) 
* Swiss mice were injected i.p. with 0.2 mlof 107~ TCIDs0 of EMCV. 
Castration was performed at4 weeks of age. 
:~ Interferon was assayed in the serum 6 h after inoculation of EMCV. 
§ Student's t-test was used for statistical nalysis. 
II NS, Not significant. 
Castration which had abrogated the sex difference in susceptibility also abrogated the 
difference in the serum interferon titres between male and female mice (Table 4). 
In summary, the analysis of 12 series of values from different experiments showed that there 
was a highly significant correlation (r = 0.84, P < 0-01) between the serum interferon titres 
at 6 h (see Table 4) and the percentage of mice surviving an i.p. injection of 104.3 TCIDso 
of EMCV (see Table 2). 
Antiviral effect of  exogenous interferon in male and female mice infected with EMCV 
As the results described above suggested that there was a correlation between the higher 
serum interferon titres early after EMCV infection in adult female mice and their greater 
resistance to EMCV infection, it was of interest to determine the efficacy of exogenous 
interferon in protecting male and female mice injected with EMCV. 
Accordingly, 4-week-old male and female Swiss mice were injected i.p. with 0.2 ml of partially 
purified mouse interferon (three groups of mice, receiving 1.6 x 106, 1.6 × 105 and 1.6 × 104 
units of interferon), and 3 h later, mice were injected i.p. with approximately 100 LDs0 of 
EMCV (i.e. 105.3 TCIDso for males and 106.3 TCIDso for females). Exogenous interferon 
conferred a similar protection to mice of both sexes (data not shown), demonstrating that sex did 
not affect the efficacy of interferon in protecting mice against EMCV infection. 
Influence of  sex on the antibody response to anti-EMCV vaccine 
Four-week-old male and female mice were immunized with a formalin-inactivated EMCV 
vaccine. Serum anti -EMCV antibody titres were determined 6 days after the third injection of 
vaccine. The results summarized in Table 5 demonstrate that after vaccination female mice 
developed higher titres of neutralizing anti -EMCV antibodies than male mice. However, when 
these vaccinated mice were subsequently injected with live EMCV, no difference was observed 
in the post-infection antibody response between male and female mice. 
EMCV vaccine did not induce the production of interferon even when the vaccine was 
injected intravenously. This finding suggests that the increased primary humoral antibody 
response to EMCV vaccine in female mice compared with male mice may have been 
independent of the interferon system. 
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Table 5. Antibody response to EMCV in vaccinated 4-week-old male and female mice 
Neutralizing antibody titre* 
No. c ~ "~ 
Expt. Sex of mice Mean Confidence interval P value t
1 M 32 142.0 41.6-484.4 "~ -<0,001 
F 32 382.7 140.0-1045.5 J 
2 M l 5 1418.4 442.6-4544.8 "~, NSll 
F 15 1652-0 560.3 4871-0j  
Treatment 
Anti-EMCV 
vaccine:~ 
Anti-EMCV 
vaccine followed 
by virulent EMCV§ 
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* Anti-EMCV neutralizing antibodies were assayed 5 days after the last injection of vaccine (expt. l) or 6 days 
after challenge with virulent EMCV (expt. 2). 
~" Student's t-test was used for statistical analysis, 
Mice received three injections i.p, of 0-2 ml of undiluted EMCV vaccine at intervals of 3 days. 
§ Mice were vaccinated as in expt. 1. Ten days after the last injection of vaccine, mice received 0-2 ml i.p. of 
108.3 TCIDs0 of virulent EMCV. 
II NS, Not significant. 
DISCUSSION 
It had previously been shown that male mice were more susceptible than female mice to 
EMCV injected i.p. (Weinstein & Chang, 1961; Friedman et aL, 1972; Boucher et al., 1975), 
although the reasons for this difference had not been elucidated. The first question to pose 
concerns the role of sex hormones. The results of Friedman et aL (1972) and our results (Table 2) 
dearly show the protective ffect of castration in male mice, and the abolition of this effect by 
testosterone r placement therapy. The results are less clear-cut in female mice. We found that 
castration rendered female mice more susceptible to infection by EMCV, whereas Friedman et 
al. (1972) found no difference. This difference in results may be related to the strain of mouse 
used [CD1 mice in the study of Friedman et al. (1972) and Swiss mice in our study]. Previous 
studies on the effect of castration of female mice on the susceptibility o coxsackievirus B1 also 
showed ifferences depending on the mouse strain used (Berkovich & Ressel, 1965, 1967). In the 
study of Friedman et al. (1972) as in ours, administration of oestradiol increased the 
susceptibility to EMCV in castrated mice of both sexes. 
The major question, however, concerns the mechanisms responsible for the difference in 
susceptibility oEMCV between male and female mice. The finding that the sex difference was 
no longer observed when EMCV was injected i.c. suggested that the host factors responsible 
underlying the sex difference acted prior to involvement of the central nervous system. 
The interferon response seemed to be one important host factor. Thus, injection of potent 
sheep antibody to mouse interferon ~/fl abolished the difference between male and female mice 
in the response to EMCV infection (Table 3) (although it enhanced the lethality of EMCV for 
both sexes). It was unlikely that male and female mice differed in their sensitivity to interferon 
as administration of potent interferon preparations afforded an equal protection to EMCV- 
infected male and female mice. We then examined the kinetics of interferon production in 
EMCV-infected male and female mice. Recent findings by Engler et al. (1982) and Zawatzky et 
al. (1982a, b) have emphasized the importance of this 'early" interferon response in herpes 
simplex virus infection in mice. Higher serum interferon levels were in fact detected in female 
mice 6 h after inoculation of EMCV (Fig. 1). 
Several findings in the work presented herein suggested that this difference in early interferon 
response (6 h) was an important factor underlying the sex difference in susceptibility to EMCV. 
(i) No difference in susceptibility to EMCV was observed in suckling (3-week-old) male and 
female mice, and no significant difference was observed in their serum interferon titres at any 
time. (ii) There was a highly significant correlation (r = 0.84, P < 0.01) between the serum 
interferon titre at 6 h and survival of EMCV-infected mice. (iii) Increased serum interferon 
titres were observed in female mice at 6 h and lower levels of circulating EMCV were detected in 
female mice (compared with male mice) at 12 and 18 h (Fig. 2). (It seems reasonable to suggest 
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that these findings were causally related.) (iv) Castration of male mice conferred a significant 
degree of protection (Table 2) and was also associated with increased serum early interferon 
titres (6 h) (Table 4). 
There have been several reports of the effects of sex hormones on the production of interferon 
in cell culture (for review, see Stewart, 1979) and in t~ivo (Kilbourne et aL, 1961 ; Giron et al., 
197la, b; Talas & Stoger, 1972). More recently, it has been shown that an X-linked locus 
influences the amount of circulating interferon in mice infected with Newcastle disease 
(DeMaeyer-Guignard et aL, 1982) or herpes implex viruses (Zawatzky et al., 1982 c; Pedersen et 
al., 1983). Our results suggest that both genetic and hormonal factors influence the kinetics of 
production of circulating interferon in weaned Swiss mice infected i.p. with EMCV. We believe 
the enhanced 'early' interferon response in female mice is related to their enhanced egree of 
resistance to EMCV. 
One other aspect of host resistance should however be mentioned: the role of humorat 
immunity. EMCV multiplies rapidly and mice die 4 to 5 days after infection. It was not feasible 
therefore to determine with any accuracy whether there was any sex difference in the antibody 
response to virulent EMCV. However, we did find a greater primary antibody response to 
formalin-inactivated EMCV in female mice than in male mice (Table 5). Higher specific 
humoral responses in female mice have already been reported in other picornavirus infections, 
i.e. mice infected with coxsackievirus B3 (Wong et al., 1977; Huber et al., 1982). The enhanced 
antibody response to inactivated EMCV appeared to be independent ofthe interferon response 
as inactivated EMCV did not induce detectable vels of circulating interferon. Nevertheless, it 
seems possible that there is some underlying mechanism common to both the accelerated 
interferon response to virulent EMCV and the increased antibody response to inactivated 
EMCV in female mice. 
Our results considered with the previous investigations mentioned above suggest hat the 
enhanced resistance to F~MCV (and other viruses, e.g. herpes implex virus) of adult female mice 
compared with male mice is related to interferon production (either kinetics or total amount 
produced). Clearly, several other factors may enhance or abrogate this sex difference and the 
difference in the interferon response: strain and age of the mouse, route of infection, etc. It 
would be of interest, nevertheless, to determine whether a difference in the early interferon 
response also underlies the increased frequency of enterovirus infections in men compared 
with women. 
We thank Ms Chantal Maury for excellent technical assistance. This work was supported in part by grants from 
the Richard Lounsbery Foundation, Simone et Cino del Duca Foundation, INSERM (contract 12 70 12), 
D.R.E.T. (contract 82-420) and the Association pour le D6veloppement dela Recherche sur le Cancer fi Villejuif. 
One of us (B.P.) is grateful to the Foundation pour la Recherche M6dicale for support. 
REFERENCES 
aERKOVICtt, S. & RESSEL, M. (1965). Effect of gonadectomy on susceptibility of the adult mouse to Coxsackie B-I 
virus infection. Proceedings of the Society Jbr Experimental Biology and Medicine 119, 690 694. 
BERKOVICH, S. & RESSEL, M. (1967). Effect of sex on susceptibility of adult mice to Coxsackie B-I virus infection. 
Archit' fi2r die gesamte Virus]brschung 22, 246-251. 
BOUCHER, D. W., HAYASHI, K., ROSENTHAL, J. & NOTKINS, A. L. (1975). Virus-induced diabetes mellitus, llI. Influence 
of the sex and strain of the host. Journal oJ InJectious Diseases 131,462 466. 
DEMAEYER-GUIGNARD, J., ZAWATZKY, R., DANDOY, F. & DEMAEYER, E. (1982). An X-linked locus influences the 
amount of circulating interferon levels in the mouse. Journa/ofln]ectious Diseases 3, 241 252. 
ENGLER, H., ZAWATZKY, R., KIRCHNER, H. & ARMERDING, D. (1982). Experimental infection of inbred mice with 
herpes implex virus. IV. Comparison of interferon production and natural killer cell activity in susceptible 
and resistant adult mice. Archi~,es of Virology 74, 239-247. 
FRANTZEN, A. (1948). On the preparation of a formalinized aluminium hydroxide vaccine with the murine S.K. 
poliomyelitis train (Jungeblut & Sanders). Acta pathologica et microbiologica scandinarica 25, 351-355. 
FRIEDMAN, S. B., GaOTA, L. J. & GLASGOW, L. A. (1972). Differential susceptibility of male and female mice to 
encephalomyocarditis virus : effects of castration, adrenalectomy and the administration of sex hormones. 
Injection and Immunity 5, 637-644. 
GIRON, D. J., ALLEN, P. T., PINDAK, F. F. & SCHMIDT, J. P. (1971 a). Inhibition by estrone of the antiviral protection 
and interferon elicited by interferon inducers in mice. Infection and Immunity 3, 318 322. 
Early interferon and sex in EMCV infection 709 
GIRON, D. J., SCHMIDT, J. P. & PINDAK, F. F. (1971b). Effect of progesterone and testosterone on interferon 
production and on the viral infection-enhancing activity of estrone and hydrocortisone. Injection and 
Immunity 4, 537-540. 
GRESSER, t., aOURAeI, C., THOMAS, M.-T. ~, FALCOFF, E. (1968). Effect of repeated inoculation of interferon 
preparations oninfection of mice with encephalomyocarditis virus. Proceedings ofthe Society for Experimental 
Biology and Medicine 127, 491-496. 
GRESSER, I., FONTAINE-BROUTY-BOYE, D., BOURALI, C. & THOMAS, M.-T. (19693. A comparison of the efficacy of 
endogenous, exogenous and combined endogenous-exogenous interferon in the treatment of mice infected 
with encephalomyocarditis virus. Proceedings ofthe Society for Experimental Biology and Medicine 130, 236- 
242. 
GRESSER, I., TOVEY, M. G., BANDU, M.-T., MAURY, C. & BROUTY-BOYE, D. (1976). Role of interferon in the pathogenesis 
of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of 
encephalomyocarditis virus infection. Journal oJ Experimental Medicine 144, 1305 1315. 
GUST, I. D., COULEPIS, A. G., FEINSTONE, S. M., LOCARNINI, S. A., MORITSUGU, Y., NAJERA, R. & SIEGE, G. (1983). 
Taxonomic lassification of hepatitis A virus. Intervirology 20, 1-7. 
HUBER, S. A., JOB, L. P., AULD, K. R. & WOODRUFF, J. F. (1981 a). Sex-related ifferences in the rapid production of 
cytotoxic spleen cells active against uninfected myofibers during Coxsackie virus B-3 infection. Journal of 
Immunology 126, 1336-1340. 
HUBER, S. a., JOB, L. P. & WOODRUFF, J. V. (1981 b). Sex-related ifferences in the pattern of Coxsackie virus B-3 
induced immune spleen cell cytotoxicity against virus-infected myofibers. Injection and Immunity 32, 68-73. 
HUBER, S. g., JOB, L. P. & AULD, K. R. (1982). Influence of sex hormones on Coxsackie B-3 virus infection in Balb/c 
mice. Cellular Immunology 67, 173 189. 
KILBOURNE, E. D., SMART, K. M. & POKORNY, B. A. (1961). Inhibition by cortisone of the synthesis and action of 
interferon. Nature, London 190, 650 651. 
McCOLLUM, R. W. (1976). Viral hepatitis. In Viral lnJbctions of Humans, pp. 235-252. Edited by A. S. Evans. 
London: John Wiley & Sons. 
MORENS, D. M., ZWEIGHAFT, R. M. & BRYAN, J. M. (19793. Non polio enterovirus disease in the United States. 
International Journal oJ Epidemiology 8, 49 54. 
NELSON, D., HIEMSTRA, H., MINOR, T. & D'ALESSIO, D. (19793. Non polio enterovirus activity in Wisconsin based on a 
20-year experiment in a diagnostic virology laboratory. American Journal qfEpidemiology 109, 352-361. 
PEDERSEN, E. B., HAAHR, S. & MOGENSEN, S. C. (1983). X-linked resistance of mice to high doses of herpes implex 
virus type 2 correlates with early interferon production. Injection and lmmunity 142, 740 746. 
PIZZI, M. (1950). Sampling variations of the fifty percent end point determined by the Reed-Muench (Behrens) 
method. Human Biology 22, 151 190. 
REED, L. J. & MUENCH, H. (19383. A simple method of estimating fifty per cent end points. American Journal oJ 
Hygiene 27, 493-497. 
STEWART, W. E. n (1979). The genetics of interferon production. In The Interjeron System, pp~ 85 87. Edited by 
W. E. Stewart II. Wieu & New York: Springer-Verlag. 
TALAS, M. & STOGER, I. (19723. Hormone pretreatment and interferon production in mice. Acta virologica 16, 211- 
216. 
TOVEY, M. G., BEGON-LOURS, J. & GRESSER, 1. (1974). A method for the large scale production of potent interferon 
preparations. Proceedings oJ the Society Jbr Experimental Biology andMedicine 146, 809-815. 
WEINSTEIN, L. (19573. Influence of age and sex on susceptibility and clinical manifestations in poliomyelitis. New 
England Journal of Medicine 257, 47-52. 
WEINSTEIN, L. & CHANG, T. W. (19613. Effect of 'sex' of tissue cultures on growth of encephalomyocarditis virus. 
Proceedings o/ the Society Jor Experimental Biology and Medicble 108, 471-474. 
WONG, C. Y., WOODRUFF, J. J. & WOODRUFF, J. F. (1977). Generation of cytotoxic T lymphocytes during Coxsackie 
virus B-3 infection. III. Role of sex. Journal oflmmunology 119, 591-597. 
WOODRUFF, J. F. (19803. Viral myocarditis. American Journal q/Pathology 101, 426 483. 
ZAWATZKY, R., ENGLER, H. & KIRCHNER, H. (1982a). Experimental infection of inbred mice with herpes implex 
virus. III. Comparison between ewborn and adult C57BL/6 mice. Journal oJGeneral Virology 60, 25-29. 
ZAWATZKY, R., GRESSER, I., DE MAEYER, E. & KIRCHNER, H. (1982b). The role of interferon in the resistance of 
C57B1/6 mice to various doses of herpes implex virus type 1. Journal oflnJectious Diseases 146, 405-410. 
ZAWATZKY, R.~ KIRCHNER, H., DEMAEYER-GUIGNARD, J. & DEMAEYER, E. (1982C). An X-linked locus influences the 
amount of circulating interferon induced in the mouse by herpes implex virus type 1. Journal of General 
Virology 63, 325-332. 
(Received 25 July 1984) 
